Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Jun 3, 2026
Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancer.
Read at PubMed CentralPubMed Central · Jun 2, 2026
Predictive Features Specific to FIGO IIIA1 Ovarian Cancer: What Drives Prognosis.
Read at PubMed CentralPubMed Central · Jun 2, 2026
Gastric Mucosal Molecular Alterations and Multimodal Field-Based Risk Models for Gastric Cancer Development.
Read at PubMed CentralPubMed Central · Jun 2, 2026
An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing.
Read at PubMed CentralPubMed Central · Jun 2, 2026
Spatial, temporal, and molecular heterogeneity of ADC targets in high-grade serous ovarian carcinoma.
Read at PubMed CentralPubMed Central · Jun 2, 2026
Subtype-Specific Alterations in Copper Trafficking Associated with KRAS Mutations in Isogenic Colorectal Cancer Cell Lines.
Read at PubMed CentralPubMed Central · Jun 1, 2026
Real-World Treatment Patterns for Patients with High-Risk Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.
Read at PubMed CentralPubMed Central · Jun 1, 2026
Nonlinear Modeling Reveals Novel Associations Between Genetically Predicted Protein Levels and Pancreatic Cancer Risk.
Read at PubMed CentralPubMed Central · Jun 1, 2026
Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse Model.
Read at PubMed CentralPubMed Central · May 30, 2026
Uveal melanoma: A review of current treatment limitations and the emerging therapeutic potential of natural killer cells.
Read at PubMed CentralPubMed Central · May 30, 2026
From Tumour to Bloodstream: Advancing PD-L1 Testing With Liquid Biopsies in Non-Small Cell Lung Cancer.
Read at PubMed CentralPubMed Central · May 30, 2026
Pilot Randomized Trial of a Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer.
Read at PubMed CentralPubMed Central · May 29, 2026
Dyadic Coping and Its Influencing Factors in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy and Their Spouses: A Latent Class Analysis.
Read at PubMed CentralPubMed Central · May 29, 2026
Oncogenic BRAF and KRAS Promote Global DNA Hypomethylation Through a Directed Pathway That Upregulates TET3.
Read at PubMed CentralPubMed Central · May 29, 2026
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis.
Read at PubMed CentralPubMed Central · May 29, 2026
The Past, Present, and Future of Sentinel Lymph Node Biopsy in Breast Cancer.
Read at PubMed CentralPubMed Central · May 29, 2026
Efficacy and safety of durvalumab with or without tremelimumab in the treatment of metastatic non-small cell lung cancer: a meta-analysis of randomized controlled trials.
Read at PubMed CentralPubMed Central · May 28, 2026
Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial.
Read at PubMed CentralPubMed Central · May 27, 2026
Diagnostic and Prognostic Values of PRAME Immunohistochemistry in Acral Lentiginous Melanoma.
Read at PubMed CentralPubMed Central · May 27, 2026
UBE2C-Mediated CD147-CTLA-4 Axis Promotes T Cell Exhaustion and Immunosuppressive Microenvironment in Bladder Cancer.
Read at PubMed Central